Cancer is ranked as the second leading cause of death globally. Traditional cancer
therapies including chemotherapy are flawed, with off-target and on-target toxicities on the …

Simple Summary Scientists have been working on the development of nanomedicine-based
tumor therapy, rather than conventional treatment, to treat cancer for several years …

Theranostics is a growing field that matches diagnostics and therapeutics. In this approach,
drugs and techniques are uniquely coupled to diagnose and treat medical conditions …

Hydroxycamptothecin (HCPT) is a natural plant alkaloid from Camptotheca that shows
potent antitumor activity by targeting intracellular topoisomerase I. However, factors such as …

Despite the recent advances in cancer therapy, triple-negative breast cancers (TNBCs) are
the most relapsing cancer sub-type. It is partly due to their propensity to develop resistance …

The introduction of cancer therapeutics and nanotechnology has resulted in a paradigm shift
from conventional therapy to precision medicine. Nanotechnology, an interdisciplinary field …

The technology of lipid nanoparticles has a long history in drug delivery, which begins with
the discovery of liposomes by Alec D Bangham in the 1960s. Since then, numerous studies …

Targeted delivery of therapeutics to specific tissues is critically important for reducing
systemic toxicity and optimizing therapeutic efficacy, especially in the case of cytotoxic …

Cancer is a leading cause of morbidity and mortality worldwide, and an increase in
incidence is estimated in the next future, due to population aging, which requires the …

Nanoparticles (NPs) exhibit remarkable potential in the diagnosis and treatment of various
liver ailments, including primary liver cancer or hepatocellular carcinoma (HCC), liver …